Výsledky vyhledávání - "K S, Skrupskiy"

Akademický článek

Lymphoblock surgical solution for the prevention of lymphogenic complications during robot-assisted radical prostatectomy and pelvic lymphadenectomy: first-use experience

Autor: K. S. Skrupskiy, K. B. Kolontarev, A. V. Govorov, V. V. Dyakov, A. M. Lukin, B. I. Dzhumabaev, D. Yu. Pushkar

Publikováno v: Vestnik Urologii, Vol 12, Iss 4, Pp 82-90 (2024)

Introduction. The clinical guidelines recommend performing extended pelvic lymph node dissection for patients with intermediateor high-risk cancer prostate. The incidence of lymphocele development reaches 10.3%.Objective. The aim of this study was to

Externí odkaz: https://doaj.org/article/181fcb5252174ca9b193248a10678cfd

Zobrazit plný text záznamu

Akademický článek

Surgical technique for preventing lymphatic complications during robot-assisted radical prostatectomy

Autor: K. S. Skrupskiy, K. B. Kolontarev, A. V. Govorov, V. V. Dyakov, A. L. Sarukhanian, I. O. Gritskov, D. Yu. Pushkar

Publikováno v: Vestnik Urologii, Vol 12, Iss 3, Pp 88-96 (2024)

Introduction. Radical prostatectomy (RP) stands the gold standard method of treatment for localised prostate cancer. Pelvic lymph node dissection (PLND) is a common surgical procedure that can be used for both diagnostic and therapeutic purposes. Lym

Externí odkaz: https://doaj.org/article/d98ff568312b461f9c831d073b6490ea

Zobrazit plný text záznamu

Long-term oncological and functional results of robot-assisted radical prostatectomy

Autor: G. P. Gens, Konstantin Kolontarev, D Yu Pushkar, A. А. Shiryaev, Yu.A. Kim, A. O. Vasilyev, A. I. Alaverdyan, K. K. Ramazanov, K. S. Skrupskiy, А. V. Sadcheko, R. V. Stroganov, Alexander Govorov

Publikováno v: Onkourologiâ, Vol 17, Iss 3, Pp 121-128 (2021)

Prostate cancer (РСа), being one of the leading causes of cancer mortality in men in Russia and in a number of other countries of the world, remains an urgent problem for modern oncourology, and the choice of surgical method is an important task f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38a75f4032e6452c608b393a65cec79e
https://oncourology.abvpress.ru/oncur/article/view/1437

Zobrazit plný text záznamu

The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-naïve patients with benign prostatic hyperplasia

Autor: K. S. Skrupskiy, A A Markov, R P Vasilevskiy, V V Soloviev, Yu A Kupriyanov, Rasner Pi, Oleg I. Epstein, A A Akrikidi, D Yu Pushkar, E V Nozdrin, I M Rokhlikov, Mikhail Putilovskiy, L A Logvinov

Publikováno v: Urologiia. :36-42

Introduction Benign prostatic hyperplasia (BPH) is one of the most common diseases in men over 50 years. The prevalence of the BPH increases with age, and pathologic features of BPH are found in about 90% of men over 80 years. Aim The aim of the stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8147c2aacb996cd55498526163f35240
https://doi.org/10.18565/urology.2019.3.36-42

Zobrazit plný text záznamu

[The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia]

Autor: Yu A, Kupriyanov, P I, Rasner, I M, Rokhlikov, A A, Akrikidi, V V, Soloviev, A A, Markov, E V, Nozdrin, L A, Logvinov, R P, Vasilevskiy, K S, Skrupskiy, D Yu, Pushkar, M A, Putilovskiy, O I, Epstein

Publikováno v: Urologiia (Moscow, Russia : 1999). (3)

Benign prostatic hyperplasia (BPH) is one of the most common diseases in men over 50 years. The prevalence of the BPH increases with age, and pathologic features of BPH are found in about 90% of men over 80 years.The aim of the study was to study the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f8d5bf375110d1aebc1a6d9acdffa145
https://pubmed.ncbi.nlm.nih.gov/31356011

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání